Objective: To examine changes in radial bone density and biochemical status, with particular reference to calcium, over 18 months in a group of older men. Subjects: Thirty-six healthy men (aged 66 ± 76 y) were recruited to the study during July and August, 1993. These men were free-living residents of Edmonton who were recruited through local organizations for the retired and semi-retired. Data for the younger group of men (age 29 ± 60 y) were taken from a previous study conducted in our laboratory. Design: Using special-purpose computed tomography (gCT), trabecular (TBD), cortical (CBD) and integral (IBD) bone densities (gmacm 3 ) were measured in the ultra-distal radius at 6-month intervals over 18 months. At baseline, and at each subsequent study visit, serum was obtained from each subject for determinations of calcium, phosphate, 25-hydroxyvitamin D, alkaline phosphatase, and immunoreactive parathyroid hormone. A 24-h urine sample was also obtained at each study visit for determination of urinary calcium, phosphate and creatinine. Results: In repeated measures analysis of variance of the data for the older men serum 25-hydroxyvitamin D was signi®cantly decreased (P`0.001) over time, while TBD was increased ( 0.60% per year, P`0.01). Longitudinal rates of change for TBD, CBD and IBD were: 7 0.94%, 0.92% and 0.74% per year respectively when bone density data at baseline for the older men and the historical data for younger men were combined. However, separate analyses of the data for the younger and the older men indicated no signi®cant age-related changes in bone density for men aged 29 ± 60 y, or for men aged 66 ± 76 y. However, differences in TBD, CBD and IBD between the younger and older groups of men were signi®cant (P`0.001). Conclusions: In a group (n 36) of older men (mean age 71.7 y) studied longitudinally over 18 months, bone density in the distal radius did not decrease over time. Mean bone density in this group of men was, however, signi®cantly (P`0.001) lower than in a group of younger men (n 17, mean age 46.7 y). Regression analysis using cross-sectional bone density data at baseline for the older male group, and historical data for the younger male group, indicates that bone loss occurs with increasing age at a rate of about 1% per year averaged over ages 29 ± 76 y. Bone density variables were not correlated with either height or weight, or with any biochemical or hormonal variable measured in this study. Sponsor: The work was funded in part by the Dairy Bureau of Canada. Descriptors: bone density; computed tomography; 25-hydroxyvitamin D; older men
Introduction
Decreased bone mass is a well-known consequence of increased age for both men and women. The cause of age-related bone loss, however, has been more carefully investigated for women than for men. Using radiographic photodensitometry (Garn, et al, 1967; Newton-John & Morgan, 1970) , photon absorptiometry (Riggs et al, 1981; Mazess, 1982; Yano et al, 1984) and quantitative computed tomography (Meier et al, 1984) , cross-sectional studies in men have provided evidence for a progressive decline in bone mass. Histomorphometric studies have also demonstrated age-related loss of both cortical and trabecular bone volume in men, and further that this bone loss appears to be the result of decreased bone formation with little or no change in bone resorption (Francis et al, 1989) . A longitudinal study involving men aged 30 ± 70 y (Orwoll et al, 1990) has shown that bone mass decreases at both axial and peripheral sites with a rate of vertebral loss of about twice that of radial bone loss (2.3% vs 1.0% per year).
While osteoporosis is still primarily considered a women's disease, the clinical approach to aging in men must also consider the consequences of skeletal degeneration as life expectancy increases. In order to improve the clinical management of age-related bone loss in men, a better understanding of causal mechanisms is necessary, and for this purpose more longitudinal studies are required. The present study was undertaken to monitor changes in radial bone density and bone mineral metabolism in healthy older caucasian men over an 18-month period.
Subjects and methods

Subjects
Through advertising in local organizations for the retired and semi-retired, 36 healthy men aged 66 ± 76 y (mean 71.7 y) were recruited to this study during the months of July and August, 1993. Subjects entered into the study were free living in the community, and had no evidence of medical conditions or took medications known to affect bone metabolism. All subjects were non-smokers who consumed only social quantities of alcohol. No subject exercised regularly or had a history of minimal trauma fracture. All subjects provided written informed consent to participate in a manner approved by an institutional Ethics Review Board.
The younger group of men (age 29 ± 60 y, mean 47 y) had participated in an earlier study conducted in our laboratory to validate the precision of the gCT method (Overton & Wheeler, 1992) . All subjects in this younger group were also healthy, had no medical condition, and took no medication known to affect bone metabolism; they also had given written informed consent to participate in that particular study.
Method Trabecular (TBD), cortical (CBD) and integral (IBD) bone densities (gacm 3 ) were measured in the ultradistal radius on four occasions, at 6-month intervals over 18 months, using special-purpose computed tomography (gCT) (Hangartner & Overton, 1982; Hangartner et al, 1987) . The distal limit of the measurement site was about 2 mm proximal to the lowest part of the end-plate and extended 14 to 18 mm (7 ± 9 CT slices) proximal from that plane. The measurement volume is usually de®ned by two parallel planes, separated by about 16 mm, which are approximately perpendicular to the long axis of the radius (Figure 1 ). For each CT slice, TBD is evaluated as the average density of the inner 45% of the slice area; IBD and CBD are de®ned over 100% and 75 ± 90% of the slice area, respectively. Averaging these values over several CT slices within this measurement volume provides TBD, CBD and IBD for a well-de®ned and accurately reproducible bone volume over repeated measurements. At each time point, duplicate measurements were made with the subject repositioned between measurements, and the average of these two measurements was used in the regression analysis for bone density on age.
At baseline, and at each study visit, serum samples were taken for determinations of ionized calcium, parathyroid hormone (intact PTH), 25-hydroxyvitamin D, and alkaline phosphatase; a 24-h urine sample in a container containing 6 molal HCl was also obtained at each study visit for determinations of urinary calcium, phosphate and creatinine. Serum ionized calcium was measured by ion-selective electrode (Ciba-Corning 634), serum immunoreactive parathyroid hormone was measured using the IRMA assay (Allegro Intact PTH, Nichols Institute, San Juan, Capistrano, CA, USA). Urine calcium was measured by¯ame absorption spectroscopy (Perkin-Elmer Z5000), urine phosphorus and creatinine were measured by colorimetric methods (Dupont ACA 3 and Beckman CX3, respectively).
Statistical analysis
Each study variable was characterized by its mean, standard deviation (s.d.) and standard error of the mean (s.e.m.). To determine longitudinal rate of change in bone density, a linear least squares regression of each bone density variable on observation time (y) was calculated with standard error of the estimate (s.e.e.) for each subject. Average rate of change in bone density, expressed as a percentage of the mid-study value predicted from the regression line was then calculated from the individual subject values. A one-sample t-test was used to determine the signi®cance of the difference in mean rate of change from zero. A multivariate, general linear model was used to test the signi®cance of changes over time for other study variables to determine interrelationships between variables, and to assess their in¯uence on rate of change in bone density. P-values`0.05 (two-tailed) were considered to be signi®cant. For the cross-sectional analysis, a linear regression on age was calculated for each bone density variable; coef®cients from these regressions were then used to estimate rates of changes in bone density with age.
Data analysis was performed using Systat (SYSTAT Inc., Evanston, IL, USA) on a personal computer.
Results
In repeated measures over time, all continuous variables were found to be distributed normally, and for each variable there was homogeneity of variance. General characteristics of the two study groups at baseline are shown in Table 1 . There were no signi®cant differences in height or weight between the older (mean age 71.7 y) or younger (mean age 47 y) groups of men, but mean values for the bone density variables (TBD, CBD and IBD) were signi®cantly higher for the younger group (P`0.001).
Regression analysis parameters for TBD, CBD and IBD on age for the combined data for the younger and older groups of men, and for the older and younger groups separately, are shown in Table 2 . Scatterplots of these data for the combined data with the regression lines are shown in Figure 2 . For men above age 66 years, the crosssectional variability in bone densities, indicated by the s.e.e. is much greater than for men below age 60 years. Annual rates of change for TBD, CBD and IBD in the ultradistal radius, determined from the longitudinal data, are Figure 1 Measurement site in the ultra-distal radius using g-CT. Bone volumes used for averaging in the determination of trabecular (TBD), cortical (CBD), and integral (IBD) bone densities are shown. Radial bone density changes in older men TR Overton and TK Basu shown in Table 3 . TBD was increased signi®cantly ( 0.6% per year, P`0.01); CBD and IBD were unchanged over this time. In a multivariate analysis of covariance, no variable measured at baseline had any signi®cant effect on rate of change in TBD, CBD or IBD. Biochemical results relating to bone metabolism are summarized in Table 4 . In repeated measures analysis of variance, 25-hydroxyvitamin D was found to be signi®-cantly decreased (P`0.001) over the study period. No signi®cant change in any other biochemical variable, including calcium, phosphate, PTH, alkaline phosphatase or creatinine was detected.
Discussion
Using special-purpose computed tomography, we made longitudinal measurements of trabecular, cortical and integral bone densities in the ultra-distal radius in a group of healthy men aged 66 ± 76 y (mean 71.1 years at entry). Measured over an 18-month period, a statistically signi®-cant increase ( 0.06% per year, P`0.01) in trabecular bone density was observed while CBD and IBD were unchanged. Regressions of the bone density variables on age were also calculated after combining the baseline data for the older group of men with historical data from a group of younger men (age 29 ± 60 y, mean 46.7 y). Crosssectional rates of change of TBD, CBD and IBD, derived from this regression analysis, were 7 0.94%, 7 0.92% and 7 0.74% respectively (Table 2, Figure 2 ). Using data for the older group of men only or for the younger group only, regression analysis indicated no signi®cant changes in the bone density variable with age. However, the variability Value given is average of individual rates of change with 95% con®dence interval (CI). Signi®cance (P) of the change per year is for a 1-sample t-test for a difference from zero; n.s., not signi®cant.
Radial bone density changes in older men TR Overton and TK Basu in the bone density data for the older group of men was much greater than that in the younger group. Age-related appendicular bone loss in men has been reported to begin between the early thirties and mid ®fties and then to continue throughout life at a slower rate (Riggs et al, 1981; Mazess, 1982; Meier et al, 1984) . In the present study, analysis of the combined cross-sectional data for the older and younger men indicates that both trabecular and cortical bone densities are decreased at a rate of about 1% per year over the age range 29 ± 76 y. This rate of loss is only slightly larger than that reported previously in crosssectional studies (Riggs et al, 1981; Meier et al, 1984; Yano et al, 1984) , and the same as that reported in a longitudinal study (Orwoll et al., 1990) . When our data for the older and younger men are analyzed separately, bone loss with age is not signi®cant for either group; however, this ®nding could be the result of the large variability in bone density indices in the older group of men, and of the small number of men in the younger group.
In a longitudinal study of bone mass in men, Orwoll et al (1990) found loss rates of 1% per year at both the distal and proximal radial sites; bone loss was reported to commence at about age 35 y and to continue throughout life. Further, in men above age 65 y the rate of bone loss in the distal radius (trabecular bone) was found to be slightly accelerated with respect to earlier bone loss, while rate of loss for the proximal radius (cortical bone) was unchanged. Our results for the combined cross-sectional data for men also indicated bone loss rates of about 1% per year for both trabecular and cortical bone at the distal radius. However, separate analyses of the cross-sectional data for the older and younger men, and our longitudinal data for the older men, suggests that men in the late seventh and early eighth decades do not continue to lose bone at the distal radius site. Our ®ndings, for both longitudinal and cross-sectional data, of no change with age in CBD or IBD in the distal radius in men aged above 66 years, agree with the crosssectional data reported by Riggs et al (1981) for this same age group. Riggs and his associates further reported no signi®cant changes in radial cortical bone mass throughout life. However, our combined cross-sectional data indicate a decrease in TBD, CBD and IBD of between 10% and 15% for men with a mean age of 71.7 y relative to men with a mean age of 47 y. Our result also con¯icts with the ®ndings of Yano et al (1984) and Orwoll et al (1990) .
The older men in our study were healthy, well-nourished, and ambulatory. Average dietary calcium intake for these subjects was 884 mgad. At baseline, mean 25-hydroxyvitamin D (122 nmolal) for the group was slightly above the normal range for our laboratory (10 ± 120 nmolal), while the mean intact PTH (36 ngal) was in the low normal range (10 ± 65 ngal). However, neither calcium intake nor baseline levels of 25-hydroxyvitamin D or PTH had any in¯uence on the measured rates of change of any bone density variable. Further, PTH was unchanged in the group over the 18-month study period, while 25-hydroxyvitamin D decreased signi®cantly (P`0.001) but remained within the normal range for this assay. This is the ®rst report of a longitudinal study in older men in which trabecular and cortical bone have been separately evaluated using high-precision gCT. Our longitudinal data substantially agree with previous crosssectional reports of little or no bone loss in older men (Riggs et al, 1981) , but do not agree with previous longitudinal study in men in which a continuing loss of bone is reported after age 65 years (Orwoll et al, 1990) . However, our cross-sectional data, including results for both older and younger men, are in general agreement with Orwoll's longitudinal results. To resolve the discrepancies between these several different investigations, prospective studies of bone loss in men throughout life are warranted. Radial bone density changes in older men TR Overton and TK Basu
